Pharma & Healthcare
Global Semi-solid Dosage Market Insights, Forecast to 2030
- Nov 02, 24
- ID: 653914
- Pages: 126
- Figures: 155
- Views: 2
The global Semi-solid Dosage market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Semi-solid Dosage include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG and GlaxoSmithKline plc, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Semi-solid Dosage, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Semi-solid Dosage, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Semi-solid Dosage, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Semi-solid Dosage sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Semi-solid Dosage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Semi-solid Dosage sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera
Crown Laboratories
Akorn
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics
Mylan N.V.
Encore Dermatology
LEO Pharma
Almirall, S.A
Aclaris Therapeutics
Taro Pharmaceutical Industries
Teligent Pharma
Perrigo Pharma
SigmaAldrich
Segment by Type
Ointment
Paste
Plaster
Gel
Segment by Application
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Semi-solid Dosage in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Semi-solid Dosage manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Semi-solid Dosage sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The US & Canada market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Semi-solid Dosage include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG and GlaxoSmithKline plc, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Semi-solid Dosage, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Semi-solid Dosage, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Semi-solid Dosage, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Semi-solid Dosage sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Semi-solid Dosage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Semi-solid Dosage sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera
Crown Laboratories
Akorn
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics
Mylan N.V.
Encore Dermatology
LEO Pharma
Almirall, S.A
Aclaris Therapeutics
Taro Pharmaceutical Industries
Teligent Pharma
Perrigo Pharma
SigmaAldrich
Segment by Type
Ointment
Paste
Plaster
Gel
Segment by Application
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Semi-solid Dosage in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Semi-solid Dosage manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Semi-solid Dosage sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Semi-solid Dosage Product Introduction
1.2 Market by Type
1.2.1 Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ointment
1.2.3 Paste
1.2.4 Plaster
1.2.5 Gel
1.3 Market by Application
1.3.1 Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Semi-solid Dosage Sales Estimates and Forecasts 2019-2030
2.2 Global Semi-solid Dosage Revenue by Region
2.2.1 Global Semi-solid Dosage Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Semi-solid Dosage Revenue by Region (2019-2024)
2.2.3 Global Semi-solid Dosage Revenue by Region (2025-2030)
2.2.4 Global Semi-solid Dosage Revenue Market Share by Region (2019-2030)
2.3 Global Semi-solid Dosage Sales Estimates and Forecasts 2019-2030
2.4 Global Semi-solid Dosage Sales by Region
2.4.1 Global Semi-solid Dosage Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Semi-solid Dosage Sales by Region (2019-2024)
2.4.3 Global Semi-solid Dosage Sales by Region (2025-2030)
2.4.4 Global Semi-solid Dosage Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Semi-solid Dosage Sales by Manufacturers
3.1.1 Global Semi-solid Dosage Sales by Manufacturers (2019-2024)
3.1.2 Global Semi-solid Dosage Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Semi-solid Dosage in 2023
3.2 Global Semi-solid Dosage Revenue by Manufacturers
3.2.1 Global Semi-solid Dosage Revenue by Manufacturers (2019-2024)
3.2.2 Global Semi-solid Dosage Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Semi-solid Dosage Revenue in 2023
3.3 Global Key Players of Semi-solid Dosage, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Semi-solid Dosage Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Semi-solid Dosage, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Semi-solid Dosage, Product Offered and Application
3.8 Global Key Manufacturers of Semi-solid Dosage, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Semi-solid Dosage Sales by Type
4.1.1 Global Semi-solid Dosage Historical Sales by Type (2019-2024)
4.1.2 Global Semi-solid Dosage Forecasted Sales by Type (2025-2030)
4.1.3 Global Semi-solid Dosage Sales Market Share by Type (2019-2030)
4.2 Global Semi-solid Dosage Revenue by Type
4.2.1 Global Semi-solid Dosage Historical Revenue by Type (2019-2024)
4.2.2 Global Semi-solid Dosage Forecasted Revenue by Type (2025-2030)
4.2.3 Global Semi-solid Dosage Revenue Market Share by Type (2019-2030)
4.3 Global Semi-solid Dosage Price by Type
4.3.1 Global Semi-solid Dosage Price by Type (2019-2024)
4.3.2 Global Semi-solid Dosage Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Semi-solid Dosage Sales by Application
5.1.1 Global Semi-solid Dosage Historical Sales by Application (2019-2024)
5.1.2 Global Semi-solid Dosage Forecasted Sales by Application (2025-2030)
5.1.3 Global Semi-solid Dosage Sales Market Share by Application (2019-2030)
5.2 Global Semi-solid Dosage Revenue by Application
5.2.1 Global Semi-solid Dosage Historical Revenue by Application (2019-2024)
5.2.2 Global Semi-solid Dosage Forecasted Revenue by Application (2025-2030)
5.2.3 Global Semi-solid Dosage Revenue Market Share by Application (2019-2030)
5.3 Global Semi-solid Dosage Price by Application
5.3.1 Global Semi-solid Dosage Price by Application (2019-2024)
5.3.2 Global Semi-solid Dosage Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Semi-solid Dosage Market Size by Type
6.1.1 US & Canada Semi-solid Dosage Sales by Type (2019-2030)
6.1.2 US & Canada Semi-solid Dosage Revenue by Type (2019-2030)
6.2 US & Canada Semi-solid Dosage Market Size by Application
6.2.1 US & Canada Semi-solid Dosage Sales by Application (2019-2030)
6.2.2 US & Canada Semi-solid Dosage Revenue by Application (2019-2030)
6.3 US & Canada Semi-solid Dosage Market Size by Country
6.3.1 US & Canada Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Semi-solid Dosage Sales by Country (2019-2030)
6.3.3 US & Canada Semi-solid Dosage Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Semi-solid Dosage Market Size by Type
7.1.1 Europe Semi-solid Dosage Sales by Type (2019-2030)
7.1.2 Europe Semi-solid Dosage Revenue by Type (2019-2030)
7.2 Europe Semi-solid Dosage Market Size by Application
7.2.1 Europe Semi-solid Dosage Sales by Application (2019-2030)
7.2.2 Europe Semi-solid Dosage Revenue by Application (2019-2030)
7.3 Europe Semi-solid Dosage Market Size by Country
7.3.1 Europe Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Semi-solid Dosage Sales by Country (2019-2030)
7.3.3 Europe Semi-solid Dosage Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Semi-solid Dosage Market Size
8.1.1 China Semi-solid Dosage Sales (2019-2030)
8.1.2 China Semi-solid Dosage Revenue (2019-2030)
8.2 China Semi-solid Dosage Market Size by Application
8.2.1 China Semi-solid Dosage Sales by Application (2019-2030)
8.2.2 China Semi-solid Dosage Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Semi-solid Dosage Market Size by Type
9.1.1 Asia Semi-solid Dosage Sales by Type (2019-2030)
9.1.2 Asia Semi-solid Dosage Revenue by Type (2019-2030)
9.2 Asia Semi-solid Dosage Market Size by Application
9.2.1 Asia Semi-solid Dosage Sales by Application (2019-2030)
9.2.2 Asia Semi-solid Dosage Revenue by Application (2019-2030)
9.3 Asia Semi-solid Dosage Sales by Region
9.3.1 Asia Semi-solid Dosage Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Semi-solid Dosage Revenue by Region (2019-2030)
9.3.3 Asia Semi-solid Dosage Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Semi-solid Dosage Market Size by Type
10.1.1 Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Semi-solid Dosage Market Size by Application
10.2.1 Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Semi-solid Dosage Sales by Country
10.3.1 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Johnson & Johnson Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Overview
11.2.3 Merck & Co Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck & Co Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bayer AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Hisamitsu Pharmaceutical
11.4.1 Hisamitsu Pharmaceutical Company Information
11.4.2 Hisamitsu Pharmaceutical Overview
11.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hisamitsu Pharmaceutical Recent Developments
11.5 Glenmark Pharmaceuticals
11.5.1 Glenmark Pharmaceuticals Company Information
11.5.2 Glenmark Pharmaceuticals Overview
11.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glenmark Pharmaceuticals Recent Developments
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Information
11.6.2 Cipla Ltd Overview
11.6.3 Cipla Ltd Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Cipla Ltd Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Ltd Recent Developments
11.7 Nestle SA
11.7.1 Nestle SA Company Information
11.7.2 Nestle SA Overview
11.7.3 Nestle SA Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Nestle SA Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nestle SA Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Overview
11.8.3 Novartis AG Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Novartis AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis AG Recent Developments
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Information
11.9.2 GlaxoSmithKline plc Overview
11.9.3 GlaxoSmithKline plc Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 GlaxoSmithKline plc Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline plc Recent Developments
11.10 Bausch Health Companies
11.10.1 Bausch Health Companies Company Information
11.10.2 Bausch Health Companies Overview
11.10.3 Bausch Health Companies Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bausch Health Companies Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bausch Health Companies Recent Developments
11.11 Allergan
11.11.1 Allergan Company Information
11.11.2 Allergan Overview
11.11.3 Allergan Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Allergan Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Allergan Recent Developments
11.12 Biofrontera
11.12.1 Biofrontera Company Information
11.12.2 Biofrontera Overview
11.12.3 Biofrontera Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Biofrontera Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Biofrontera Recent Developments
11.13 Crown Laboratories
11.13.1 Crown Laboratories Company Information
11.13.2 Crown Laboratories Overview
11.13.3 Crown Laboratories Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Crown Laboratories Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Crown Laboratories Recent Developments
11.14 Akorn
11.14.1 Akorn Company Information
11.14.2 Akorn Overview
11.14.3 Akorn Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Akorn Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Akorn Recent Developments
11.15 Ingenus Pharmaceuticals
11.15.1 Ingenus Pharmaceuticals Company Information
11.15.2 Ingenus Pharmaceuticals Overview
11.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ingenus Pharmaceuticals Recent Developments
11.16 Sun Pharmaceuticals
11.16.1 Sun Pharmaceuticals Company Information
11.16.2 Sun Pharmaceuticals Overview
11.16.3 Sun Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Sun Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sun Pharmaceuticals Recent Developments
11.17 Crescita Therapeutics
11.17.1 Crescita Therapeutics Company Information
11.17.2 Crescita Therapeutics Overview
11.17.3 Crescita Therapeutics Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Crescita Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Crescita Therapeutics Recent Developments
11.18 Mylan N.V.
11.18.1 Mylan N.V. Company Information
11.18.2 Mylan N.V. Overview
11.18.3 Mylan N.V. Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Mylan N.V. Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Mylan N.V. Recent Developments
11.19 Encore Dermatology
11.19.1 Encore Dermatology Company Information
11.19.2 Encore Dermatology Overview
11.19.3 Encore Dermatology Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Encore Dermatology Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Encore Dermatology Recent Developments
11.20 LEO Pharma
11.20.1 LEO Pharma Company Information
11.20.2 LEO Pharma Overview
11.20.3 LEO Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 LEO Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 LEO Pharma Recent Developments
11.21 Almirall, S.A
11.21.1 Almirall, S.A Company Information
11.21.2 Almirall, S.A Overview
11.21.3 Almirall, S.A Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Almirall, S.A Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Almirall, S.A Recent Developments
11.22 Aclaris Therapeutics
11.22.1 Aclaris Therapeutics Company Information
11.22.2 Aclaris Therapeutics Overview
11.22.3 Aclaris Therapeutics Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.22.4 Aclaris Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Aclaris Therapeutics Recent Developments
11.23 Taro Pharmaceutical Industries
11.23.1 Taro Pharmaceutical Industries Company Information
11.23.2 Taro Pharmaceutical Industries Overview
11.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Taro Pharmaceutical Industries Recent Developments
11.24 Teligent Pharma
11.24.1 Teligent Pharma Company Information
11.24.2 Teligent Pharma Overview
11.24.3 Teligent Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.24.4 Teligent Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Teligent Pharma Recent Developments
11.25 Perrigo Pharma
11.25.1 Perrigo Pharma Company Information
11.25.2 Perrigo Pharma Overview
11.25.3 Perrigo Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.25.4 Perrigo Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Perrigo Pharma Recent Developments
11.26 SigmaAldrich
11.26.1 SigmaAldrich Company Information
11.26.2 SigmaAldrich Overview
11.26.3 SigmaAldrich Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.26.4 SigmaAldrich Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 SigmaAldrich Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Semi-solid Dosage Industry Chain Analysis
12.2 Semi-solid Dosage Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Semi-solid Dosage Production Mode & Process
12.4 Semi-solid Dosage Sales and Marketing
12.4.1 Semi-solid Dosage Sales Channels
12.4.2 Semi-solid Dosage Distributors
12.5 Semi-solid Dosage Customers
13 Market Dynamics
13.1 Semi-solid Dosage Industry Trends
13.2 Semi-solid Dosage Market Drivers
13.3 Semi-solid Dosage Market Challenges
13.4 Semi-solid Dosage Market Restraints
14 Key Findings in The Global Semi-solid Dosage Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Semi-solid Dosage Product Introduction
1.2 Market by Type
1.2.1 Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ointment
1.2.3 Paste
1.2.4 Plaster
1.2.5 Gel
1.3 Market by Application
1.3.1 Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Semi-solid Dosage Sales Estimates and Forecasts 2019-2030
2.2 Global Semi-solid Dosage Revenue by Region
2.2.1 Global Semi-solid Dosage Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Semi-solid Dosage Revenue by Region (2019-2024)
2.2.3 Global Semi-solid Dosage Revenue by Region (2025-2030)
2.2.4 Global Semi-solid Dosage Revenue Market Share by Region (2019-2030)
2.3 Global Semi-solid Dosage Sales Estimates and Forecasts 2019-2030
2.4 Global Semi-solid Dosage Sales by Region
2.4.1 Global Semi-solid Dosage Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Semi-solid Dosage Sales by Region (2019-2024)
2.4.3 Global Semi-solid Dosage Sales by Region (2025-2030)
2.4.4 Global Semi-solid Dosage Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Semi-solid Dosage Sales by Manufacturers
3.1.1 Global Semi-solid Dosage Sales by Manufacturers (2019-2024)
3.1.2 Global Semi-solid Dosage Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Semi-solid Dosage in 2023
3.2 Global Semi-solid Dosage Revenue by Manufacturers
3.2.1 Global Semi-solid Dosage Revenue by Manufacturers (2019-2024)
3.2.2 Global Semi-solid Dosage Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Semi-solid Dosage Revenue in 2023
3.3 Global Key Players of Semi-solid Dosage, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Semi-solid Dosage Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Semi-solid Dosage, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Semi-solid Dosage, Product Offered and Application
3.8 Global Key Manufacturers of Semi-solid Dosage, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Semi-solid Dosage Sales by Type
4.1.1 Global Semi-solid Dosage Historical Sales by Type (2019-2024)
4.1.2 Global Semi-solid Dosage Forecasted Sales by Type (2025-2030)
4.1.3 Global Semi-solid Dosage Sales Market Share by Type (2019-2030)
4.2 Global Semi-solid Dosage Revenue by Type
4.2.1 Global Semi-solid Dosage Historical Revenue by Type (2019-2024)
4.2.2 Global Semi-solid Dosage Forecasted Revenue by Type (2025-2030)
4.2.3 Global Semi-solid Dosage Revenue Market Share by Type (2019-2030)
4.3 Global Semi-solid Dosage Price by Type
4.3.1 Global Semi-solid Dosage Price by Type (2019-2024)
4.3.2 Global Semi-solid Dosage Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Semi-solid Dosage Sales by Application
5.1.1 Global Semi-solid Dosage Historical Sales by Application (2019-2024)
5.1.2 Global Semi-solid Dosage Forecasted Sales by Application (2025-2030)
5.1.3 Global Semi-solid Dosage Sales Market Share by Application (2019-2030)
5.2 Global Semi-solid Dosage Revenue by Application
5.2.1 Global Semi-solid Dosage Historical Revenue by Application (2019-2024)
5.2.2 Global Semi-solid Dosage Forecasted Revenue by Application (2025-2030)
5.2.3 Global Semi-solid Dosage Revenue Market Share by Application (2019-2030)
5.3 Global Semi-solid Dosage Price by Application
5.3.1 Global Semi-solid Dosage Price by Application (2019-2024)
5.3.2 Global Semi-solid Dosage Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Semi-solid Dosage Market Size by Type
6.1.1 US & Canada Semi-solid Dosage Sales by Type (2019-2030)
6.1.2 US & Canada Semi-solid Dosage Revenue by Type (2019-2030)
6.2 US & Canada Semi-solid Dosage Market Size by Application
6.2.1 US & Canada Semi-solid Dosage Sales by Application (2019-2030)
6.2.2 US & Canada Semi-solid Dosage Revenue by Application (2019-2030)
6.3 US & Canada Semi-solid Dosage Market Size by Country
6.3.1 US & Canada Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Semi-solid Dosage Sales by Country (2019-2030)
6.3.3 US & Canada Semi-solid Dosage Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Semi-solid Dosage Market Size by Type
7.1.1 Europe Semi-solid Dosage Sales by Type (2019-2030)
7.1.2 Europe Semi-solid Dosage Revenue by Type (2019-2030)
7.2 Europe Semi-solid Dosage Market Size by Application
7.2.1 Europe Semi-solid Dosage Sales by Application (2019-2030)
7.2.2 Europe Semi-solid Dosage Revenue by Application (2019-2030)
7.3 Europe Semi-solid Dosage Market Size by Country
7.3.1 Europe Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Semi-solid Dosage Sales by Country (2019-2030)
7.3.3 Europe Semi-solid Dosage Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Semi-solid Dosage Market Size
8.1.1 China Semi-solid Dosage Sales (2019-2030)
8.1.2 China Semi-solid Dosage Revenue (2019-2030)
8.2 China Semi-solid Dosage Market Size by Application
8.2.1 China Semi-solid Dosage Sales by Application (2019-2030)
8.2.2 China Semi-solid Dosage Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Semi-solid Dosage Market Size by Type
9.1.1 Asia Semi-solid Dosage Sales by Type (2019-2030)
9.1.2 Asia Semi-solid Dosage Revenue by Type (2019-2030)
9.2 Asia Semi-solid Dosage Market Size by Application
9.2.1 Asia Semi-solid Dosage Sales by Application (2019-2030)
9.2.2 Asia Semi-solid Dosage Revenue by Application (2019-2030)
9.3 Asia Semi-solid Dosage Sales by Region
9.3.1 Asia Semi-solid Dosage Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Semi-solid Dosage Revenue by Region (2019-2030)
9.3.3 Asia Semi-solid Dosage Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Semi-solid Dosage Market Size by Type
10.1.1 Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Semi-solid Dosage Market Size by Application
10.2.1 Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Semi-solid Dosage Sales by Country
10.3.1 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Johnson & Johnson Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Overview
11.2.3 Merck & Co Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck & Co Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bayer AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Hisamitsu Pharmaceutical
11.4.1 Hisamitsu Pharmaceutical Company Information
11.4.2 Hisamitsu Pharmaceutical Overview
11.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hisamitsu Pharmaceutical Recent Developments
11.5 Glenmark Pharmaceuticals
11.5.1 Glenmark Pharmaceuticals Company Information
11.5.2 Glenmark Pharmaceuticals Overview
11.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glenmark Pharmaceuticals Recent Developments
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Information
11.6.2 Cipla Ltd Overview
11.6.3 Cipla Ltd Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Cipla Ltd Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Ltd Recent Developments
11.7 Nestle SA
11.7.1 Nestle SA Company Information
11.7.2 Nestle SA Overview
11.7.3 Nestle SA Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Nestle SA Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nestle SA Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Overview
11.8.3 Novartis AG Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Novartis AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis AG Recent Developments
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Information
11.9.2 GlaxoSmithKline plc Overview
11.9.3 GlaxoSmithKline plc Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 GlaxoSmithKline plc Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline plc Recent Developments
11.10 Bausch Health Companies
11.10.1 Bausch Health Companies Company Information
11.10.2 Bausch Health Companies Overview
11.10.3 Bausch Health Companies Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bausch Health Companies Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bausch Health Companies Recent Developments
11.11 Allergan
11.11.1 Allergan Company Information
11.11.2 Allergan Overview
11.11.3 Allergan Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Allergan Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Allergan Recent Developments
11.12 Biofrontera
11.12.1 Biofrontera Company Information
11.12.2 Biofrontera Overview
11.12.3 Biofrontera Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Biofrontera Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Biofrontera Recent Developments
11.13 Crown Laboratories
11.13.1 Crown Laboratories Company Information
11.13.2 Crown Laboratories Overview
11.13.3 Crown Laboratories Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Crown Laboratories Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Crown Laboratories Recent Developments
11.14 Akorn
11.14.1 Akorn Company Information
11.14.2 Akorn Overview
11.14.3 Akorn Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Akorn Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Akorn Recent Developments
11.15 Ingenus Pharmaceuticals
11.15.1 Ingenus Pharmaceuticals Company Information
11.15.2 Ingenus Pharmaceuticals Overview
11.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ingenus Pharmaceuticals Recent Developments
11.16 Sun Pharmaceuticals
11.16.1 Sun Pharmaceuticals Company Information
11.16.2 Sun Pharmaceuticals Overview
11.16.3 Sun Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Sun Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sun Pharmaceuticals Recent Developments
11.17 Crescita Therapeutics
11.17.1 Crescita Therapeutics Company Information
11.17.2 Crescita Therapeutics Overview
11.17.3 Crescita Therapeutics Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Crescita Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Crescita Therapeutics Recent Developments
11.18 Mylan N.V.
11.18.1 Mylan N.V. Company Information
11.18.2 Mylan N.V. Overview
11.18.3 Mylan N.V. Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Mylan N.V. Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Mylan N.V. Recent Developments
11.19 Encore Dermatology
11.19.1 Encore Dermatology Company Information
11.19.2 Encore Dermatology Overview
11.19.3 Encore Dermatology Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Encore Dermatology Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Encore Dermatology Recent Developments
11.20 LEO Pharma
11.20.1 LEO Pharma Company Information
11.20.2 LEO Pharma Overview
11.20.3 LEO Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 LEO Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 LEO Pharma Recent Developments
11.21 Almirall, S.A
11.21.1 Almirall, S.A Company Information
11.21.2 Almirall, S.A Overview
11.21.3 Almirall, S.A Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Almirall, S.A Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Almirall, S.A Recent Developments
11.22 Aclaris Therapeutics
11.22.1 Aclaris Therapeutics Company Information
11.22.2 Aclaris Therapeutics Overview
11.22.3 Aclaris Therapeutics Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.22.4 Aclaris Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Aclaris Therapeutics Recent Developments
11.23 Taro Pharmaceutical Industries
11.23.1 Taro Pharmaceutical Industries Company Information
11.23.2 Taro Pharmaceutical Industries Overview
11.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Taro Pharmaceutical Industries Recent Developments
11.24 Teligent Pharma
11.24.1 Teligent Pharma Company Information
11.24.2 Teligent Pharma Overview
11.24.3 Teligent Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.24.4 Teligent Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Teligent Pharma Recent Developments
11.25 Perrigo Pharma
11.25.1 Perrigo Pharma Company Information
11.25.2 Perrigo Pharma Overview
11.25.3 Perrigo Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.25.4 Perrigo Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Perrigo Pharma Recent Developments
11.26 SigmaAldrich
11.26.1 SigmaAldrich Company Information
11.26.2 SigmaAldrich Overview
11.26.3 SigmaAldrich Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.26.4 SigmaAldrich Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 SigmaAldrich Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Semi-solid Dosage Industry Chain Analysis
12.2 Semi-solid Dosage Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Semi-solid Dosage Production Mode & Process
12.4 Semi-solid Dosage Sales and Marketing
12.4.1 Semi-solid Dosage Sales Channels
12.4.2 Semi-solid Dosage Distributors
12.5 Semi-solid Dosage Customers
13 Market Dynamics
13.1 Semi-solid Dosage Industry Trends
13.2 Semi-solid Dosage Market Drivers
13.3 Semi-solid Dosage Market Challenges
13.4 Semi-solid Dosage Market Restraints
14 Key Findings in The Global Semi-solid Dosage Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Ointment
Table 3. Major Manufacturers of Paste
Table 4. Major Manufacturers of Plaster
Table 5. Major Manufacturers of Gel
Table 6. Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Semi-solid Dosage Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Semi-solid Dosage Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Semi-solid Dosage Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Semi-solid Dosage Revenue Market Share by Region (2019-2024)
Table 11. Global Semi-solid Dosage Revenue Market Share by Region (2025-2030)
Table 12. Global Semi-solid Dosage Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Semi-solid Dosage Sales by Region (2019-2024) & (K Units)
Table 14. Global Semi-solid Dosage Sales by Region (2025-2030) & (K Units)
Table 15. Global Semi-solid Dosage Sales Market Share by Region (2019-2024)
Table 16. Global Semi-solid Dosage Sales Market Share by Region (2025-2030)
Table 17. Global Semi-solid Dosage Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Semi-solid Dosage Sales Share by Manufacturers (2019-2024)
Table 19. Global Semi-solid Dosage Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Semi-solid Dosage Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Semi-solid Dosage, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Semi-solid Dosage Price by Manufacturers 2019-2024 (USD/Unit)
Table 23. Global Semi-solid Dosage Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Semi-solid Dosage by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-solid Dosage as of 2023)
Table 25. Global Key Manufacturers of Semi-solid Dosage, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Semi-solid Dosage, Product Offered and Application
Table 27. Global Key Manufacturers of Semi-solid Dosage, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 30. Global Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 31. Global Semi-solid Dosage Sales Share by Type (2019-2024)
Table 32. Global Semi-solid Dosage Sales Share by Type (2025-2030)
Table 33. Global Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Semi-solid Dosage Revenue Share by Type (2019-2024)
Table 36. Global Semi-solid Dosage Revenue Share by Type (2025-2030)
Table 37. Semi-solid Dosage Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Semi-solid Dosage Price Forecast by Type (2025-2030) & (USD/Unit)
Table 39. Global Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 40. Global Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 41. Global Semi-solid Dosage Sales Share by Application (2019-2024)
Table 42. Global Semi-solid Dosage Sales Share by Application (2025-2030)
Table 43. Global Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Semi-solid Dosage Revenue Share by Application (2019-2024)
Table 46. Global Semi-solid Dosage Revenue Share by Application (2025-2030)
Table 47. Semi-solid Dosage Price by Application (2019-2024) & (USD/Unit)
Table 48. Global Semi-solid Dosage Price Forecast by Application (2025-2030) & (USD/Unit)
Table 49. US & Canada Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Semi-solid Dosage Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Semi-solid Dosage Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Semi-solid Dosage Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Semi-solid Dosage Sales by Country (2025-2030) & (K Units)
Table 62. Europe Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 63. Europe Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 64. Europe Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 67. Europe Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 68. Europe Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Semi-solid Dosage Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Semi-solid Dosage Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Semi-solid Dosage Sales by Country (2019-2024) & (K Units)
Table 74. Europe Semi-solid Dosage Sales by Country (2025-2030) & (K Units)
Table 75. China Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 76. China Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 77. China Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 80. China Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 81. China Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 84. Asia Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 85. Asia Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 88. Asia Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 89. Asia Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Semi-solid Dosage Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Semi-solid Dosage Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Semi-solid Dosage Sales by Region (2019-2024) & (K Units)
Table 95. Asia Semi-solid Dosage Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2025-2030) & (K Units)
Table 109. Johnson & Johnson Company Information
Table 110. Johnson & Johnson Description and Major Businesses
Table 111. Johnson & Johnson Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Johnson & Johnson Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Johnson & Johnson Recent Developments
Table 114. Merck & Co Company Information
Table 115. Merck & Co Description and Major Businesses
Table 116. Merck & Co Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Merck & Co Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Merck & Co Recent Developments
Table 119. Bayer AG Company Information
Table 120. Bayer AG Description and Major Businesses
Table 121. Bayer AG Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Bayer AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Bayer AG Recent Developments
Table 124. Hisamitsu Pharmaceutical Company Information
Table 125. Hisamitsu Pharmaceutical Description and Major Businesses
Table 126. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Hisamitsu Pharmaceutical Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Hisamitsu Pharmaceutical Recent Developments
Table 129. Glenmark Pharmaceuticals Company Information
Table 130. Glenmark Pharmaceuticals Description and Major Businesses
Table 131. Glenmark Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Glenmark Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Glenmark Pharmaceuticals Recent Developments
Table 134. Cipla Ltd Company Information
Table 135. Cipla Ltd Description and Major Businesses
Table 136. Cipla Ltd Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Cipla Ltd Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Cipla Ltd Recent Developments
Table 139. Nestle SA Company Information
Table 140. Nestle SA Description and Major Businesses
Table 141. Nestle SA Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Nestle SA Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Nestle SA Recent Developments
Table 144. Novartis AG Company Information
Table 145. Novartis AG Description and Major Businesses
Table 146. Novartis AG Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. Novartis AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Novartis AG Recent Developments
Table 149. GlaxoSmithKline plc Company Information
Table 150. GlaxoSmithKline plc Description and Major Businesses
Table 151. GlaxoSmithKline plc Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. GlaxoSmithKline plc Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. GlaxoSmithKline plc Recent Developments
Table 154. Bausch Health Companies Company Information
Table 155. Bausch Health Companies Description and Major Businesses
Table 156. Bausch Health Companies Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. Bausch Health Companies Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Bausch Health Companies Recent Developments
Table 159. Allergan Company Information
Table 160. Allergan Description and Major Businesses
Table 161. Allergan Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Allergan Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Allergan Recent Developments
Table 164. Biofrontera Company Information
Table 165. Biofrontera Description and Major Businesses
Table 166. Biofrontera Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. Biofrontera Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Biofrontera Recent Developments
Table 169. Crown Laboratories Company Information
Table 170. Crown Laboratories Description and Major Businesses
Table 171. Crown Laboratories Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Crown Laboratories Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Crown Laboratories Recent Developments
Table 174. Akorn Company Information
Table 175. Akorn Description and Major Businesses
Table 176. Akorn Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 177. Akorn Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Akorn Recent Developments
Table 179. Ingenus Pharmaceuticals Company Information
Table 180. Ingenus Pharmaceuticals Description and Major Businesses
Table 181. Ingenus Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 182. Ingenus Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Ingenus Pharmaceuticals Recent Developments
Table 184. Sun Pharmaceuticals Company Information
Table 185. Sun Pharmaceuticals Description and Major Businesses
Table 186. Sun Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 187. Sun Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Sun Pharmaceuticals Recent Developments
Table 189. Crescita Therapeutics Company Information
Table 190. Crescita Therapeutics Description and Major Businesses
Table 191. Crescita Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 192. Crescita Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Crescita Therapeutics Recent Developments
Table 194. Mylan N.V. Company Information
Table 195. Mylan N.V. Description and Major Businesses
Table 196. Mylan N.V. Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 197. Mylan N.V. Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Mylan N.V. Recent Developments
Table 199. Encore Dermatology Company Information
Table 200. Encore Dermatology Description and Major Businesses
Table 201. Encore Dermatology Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 202. Encore Dermatology Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Encore Dermatology Recent Developments
Table 204. LEO Pharma Company Information
Table 205. LEO Pharma Description and Major Businesses
Table 206. LEO Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 207. LEO Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. LEO Pharma Recent Developments
Table 209. Almirall, S.A Company Information
Table 210. Almirall, S.A Description and Major Businesses
Table 211. Almirall, S.A Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 212. Almirall, S.A Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 213. Almirall, S.A Recent Developments
Table 214. Aclaris Therapeutics Company Information
Table 215. Aclaris Therapeutics Description and Major Businesses
Table 216. Aclaris Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 217. Aclaris Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 218. Aclaris Therapeutics Recent Developments
Table 219. Taro Pharmaceutical Industries Company Information
Table 220. Taro Pharmaceutical Industries Description and Major Businesses
Table 221. Taro Pharmaceutical Industries Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 222. Taro Pharmaceutical Industries Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 223. Taro Pharmaceutical Industries Recent Developments
Table 224. Teligent Pharma Company Information
Table 225. Teligent Pharma Description and Major Businesses
Table 226. Teligent Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 227. Teligent Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 228. Teligent Pharma Recent Developments
Table 229. Perrigo Pharma Company Information
Table 230. Perrigo Pharma Description and Major Businesses
Table 231. Perrigo Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 232. Perrigo Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 233. Perrigo Pharma Recent Developments
Table 234. SigmaAldrich Company Information
Table 235. SigmaAldrich Description and Major Businesses
Table 236. SigmaAldrich Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 237. SigmaAldrich Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 238. SigmaAldrich Recent Developments
Table 239. Key Raw Materials Lists
Table 240. Raw Materials Key Suppliers Lists
Table 241. Semi-solid Dosage Distributors List
Table 242. Semi-solid Dosage Customers List
Table 243. Semi-solid Dosage Market Trends
Table 244. Semi-solid Dosage Market Drivers
Table 245. Semi-solid Dosage Market Challenges
Table 246. Semi-solid Dosage Market Restraints
Table 247. Research Programs/Design for This Report
Table 248. Key Data Information from Secondary Sources
Table 249. Key Data Information from Primary Sources
List of Figures
Figure 1. Semi-solid Dosage Product Picture
Figure 2. Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Semi-solid Dosage Market Share by Type in 2023 & 2030
Figure 4. Ointment Product Picture
Figure 5. Paste Product Picture
Figure 6. Plaster Product Picture
Figure 7. Gel Product Picture
Figure 8. Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Semi-solid Dosage Market Share by Application in 2023 & 2030
Figure 10. Skin
Figure 11. Nasal Cavity
Figure 12. Vaginal Cavity
Figure 13. Rectal Cavity
Figure 14. Others
Figure 15. Semi-solid Dosage Report Years Considered
Figure 16. Global Semi-solid Dosage Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Semi-solid Dosage Revenue 2019-2030 (US$ Million)
Figure 18. Global Semi-solid Dosage Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Semi-solid Dosage Revenue Market Share by Region (2019-2030)
Figure 20. Global Semi-solid Dosage Sales 2019-2030 ((K Units)
Figure 21. Global Semi-solid Dosage Sales Market Share by Region (2019-2030)
Figure 22. US & Canada Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 23. US & Canada Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 25. Europe Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 27. China Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 29. Asia (excluding China) Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 31. Middle East, Africa and Latin America Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The Semi-solid Dosage Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of Semi-solid Dosage in the World: Market Share by Semi-solid Dosage Revenue in 2023
Figure 34. Global Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 36. Global Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 37. Global Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 38. Global Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 40. US & Canada Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 42. US & Canada Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Semi-solid Dosage Revenue Share by Country (2019-2030)
Figure 44. US & Canada Semi-solid Dosage Sales Share by Country (2019-2030)
Figure 45. U.S. Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 48. Europe Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 49. Europe Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 50. Europe Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 51. Europe Semi-solid Dosage Revenue Share by Country (2019-2030)
Figure 52. Europe Semi-solid Dosage Sales Share by Country (2019-2030)
Figure 53. Germany Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 54. France Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 58. China Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 59. China Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 60. China Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 61. China Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 62. Asia Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 63. Asia Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 64. Asia Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 65. Asia Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 66. Asia Semi-solid Dosage Revenue Share by Region (2019-2030)
Figure 67. Asia Semi-solid Dosage Sales Share by Region (2019-2030)
Figure 68. Japan Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 72. India Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Semi-solid Dosage Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America Semi-solid Dosage Sales Share by Country (2019-2030)
Figure 79. Brazil Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 82. Israel Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 84. Semi-solid Dosage Value Chain
Figure 85. Semi-solid Dosage Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Ointment
Table 3. Major Manufacturers of Paste
Table 4. Major Manufacturers of Plaster
Table 5. Major Manufacturers of Gel
Table 6. Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Semi-solid Dosage Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Semi-solid Dosage Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Semi-solid Dosage Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Semi-solid Dosage Revenue Market Share by Region (2019-2024)
Table 11. Global Semi-solid Dosage Revenue Market Share by Region (2025-2030)
Table 12. Global Semi-solid Dosage Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Semi-solid Dosage Sales by Region (2019-2024) & (K Units)
Table 14. Global Semi-solid Dosage Sales by Region (2025-2030) & (K Units)
Table 15. Global Semi-solid Dosage Sales Market Share by Region (2019-2024)
Table 16. Global Semi-solid Dosage Sales Market Share by Region (2025-2030)
Table 17. Global Semi-solid Dosage Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Semi-solid Dosage Sales Share by Manufacturers (2019-2024)
Table 19. Global Semi-solid Dosage Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Semi-solid Dosage Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Semi-solid Dosage, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Semi-solid Dosage Price by Manufacturers 2019-2024 (USD/Unit)
Table 23. Global Semi-solid Dosage Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Semi-solid Dosage by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-solid Dosage as of 2023)
Table 25. Global Key Manufacturers of Semi-solid Dosage, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Semi-solid Dosage, Product Offered and Application
Table 27. Global Key Manufacturers of Semi-solid Dosage, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 30. Global Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 31. Global Semi-solid Dosage Sales Share by Type (2019-2024)
Table 32. Global Semi-solid Dosage Sales Share by Type (2025-2030)
Table 33. Global Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Semi-solid Dosage Revenue Share by Type (2019-2024)
Table 36. Global Semi-solid Dosage Revenue Share by Type (2025-2030)
Table 37. Semi-solid Dosage Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Semi-solid Dosage Price Forecast by Type (2025-2030) & (USD/Unit)
Table 39. Global Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 40. Global Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 41. Global Semi-solid Dosage Sales Share by Application (2019-2024)
Table 42. Global Semi-solid Dosage Sales Share by Application (2025-2030)
Table 43. Global Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Semi-solid Dosage Revenue Share by Application (2019-2024)
Table 46. Global Semi-solid Dosage Revenue Share by Application (2025-2030)
Table 47. Semi-solid Dosage Price by Application (2019-2024) & (USD/Unit)
Table 48. Global Semi-solid Dosage Price Forecast by Application (2025-2030) & (USD/Unit)
Table 49. US & Canada Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Semi-solid Dosage Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Semi-solid Dosage Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Semi-solid Dosage Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Semi-solid Dosage Sales by Country (2025-2030) & (K Units)
Table 62. Europe Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 63. Europe Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 64. Europe Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 67. Europe Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 68. Europe Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Semi-solid Dosage Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Semi-solid Dosage Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Semi-solid Dosage Sales by Country (2019-2024) & (K Units)
Table 74. Europe Semi-solid Dosage Sales by Country (2025-2030) & (K Units)
Table 75. China Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 76. China Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 77. China Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 80. China Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 81. China Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 84. Asia Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 85. Asia Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 88. Asia Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 89. Asia Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Semi-solid Dosage Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Semi-solid Dosage Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Semi-solid Dosage Sales by Region (2019-2024) & (K Units)
Table 95. Asia Semi-solid Dosage Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Semi-solid Dosage Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2025-2030) & (K Units)
Table 109. Johnson & Johnson Company Information
Table 110. Johnson & Johnson Description and Major Businesses
Table 111. Johnson & Johnson Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Johnson & Johnson Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Johnson & Johnson Recent Developments
Table 114. Merck & Co Company Information
Table 115. Merck & Co Description and Major Businesses
Table 116. Merck & Co Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Merck & Co Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Merck & Co Recent Developments
Table 119. Bayer AG Company Information
Table 120. Bayer AG Description and Major Businesses
Table 121. Bayer AG Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Bayer AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Bayer AG Recent Developments
Table 124. Hisamitsu Pharmaceutical Company Information
Table 125. Hisamitsu Pharmaceutical Description and Major Businesses
Table 126. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Hisamitsu Pharmaceutical Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Hisamitsu Pharmaceutical Recent Developments
Table 129. Glenmark Pharmaceuticals Company Information
Table 130. Glenmark Pharmaceuticals Description and Major Businesses
Table 131. Glenmark Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Glenmark Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Glenmark Pharmaceuticals Recent Developments
Table 134. Cipla Ltd Company Information
Table 135. Cipla Ltd Description and Major Businesses
Table 136. Cipla Ltd Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Cipla Ltd Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Cipla Ltd Recent Developments
Table 139. Nestle SA Company Information
Table 140. Nestle SA Description and Major Businesses
Table 141. Nestle SA Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Nestle SA Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Nestle SA Recent Developments
Table 144. Novartis AG Company Information
Table 145. Novartis AG Description and Major Businesses
Table 146. Novartis AG Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. Novartis AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Novartis AG Recent Developments
Table 149. GlaxoSmithKline plc Company Information
Table 150. GlaxoSmithKline plc Description and Major Businesses
Table 151. GlaxoSmithKline plc Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. GlaxoSmithKline plc Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. GlaxoSmithKline plc Recent Developments
Table 154. Bausch Health Companies Company Information
Table 155. Bausch Health Companies Description and Major Businesses
Table 156. Bausch Health Companies Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. Bausch Health Companies Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Bausch Health Companies Recent Developments
Table 159. Allergan Company Information
Table 160. Allergan Description and Major Businesses
Table 161. Allergan Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Allergan Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Allergan Recent Developments
Table 164. Biofrontera Company Information
Table 165. Biofrontera Description and Major Businesses
Table 166. Biofrontera Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. Biofrontera Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Biofrontera Recent Developments
Table 169. Crown Laboratories Company Information
Table 170. Crown Laboratories Description and Major Businesses
Table 171. Crown Laboratories Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Crown Laboratories Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Crown Laboratories Recent Developments
Table 174. Akorn Company Information
Table 175. Akorn Description and Major Businesses
Table 176. Akorn Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 177. Akorn Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Akorn Recent Developments
Table 179. Ingenus Pharmaceuticals Company Information
Table 180. Ingenus Pharmaceuticals Description and Major Businesses
Table 181. Ingenus Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 182. Ingenus Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Ingenus Pharmaceuticals Recent Developments
Table 184. Sun Pharmaceuticals Company Information
Table 185. Sun Pharmaceuticals Description and Major Businesses
Table 186. Sun Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 187. Sun Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Sun Pharmaceuticals Recent Developments
Table 189. Crescita Therapeutics Company Information
Table 190. Crescita Therapeutics Description and Major Businesses
Table 191. Crescita Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 192. Crescita Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Crescita Therapeutics Recent Developments
Table 194. Mylan N.V. Company Information
Table 195. Mylan N.V. Description and Major Businesses
Table 196. Mylan N.V. Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 197. Mylan N.V. Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Mylan N.V. Recent Developments
Table 199. Encore Dermatology Company Information
Table 200. Encore Dermatology Description and Major Businesses
Table 201. Encore Dermatology Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 202. Encore Dermatology Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Encore Dermatology Recent Developments
Table 204. LEO Pharma Company Information
Table 205. LEO Pharma Description and Major Businesses
Table 206. LEO Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 207. LEO Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. LEO Pharma Recent Developments
Table 209. Almirall, S.A Company Information
Table 210. Almirall, S.A Description and Major Businesses
Table 211. Almirall, S.A Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 212. Almirall, S.A Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 213. Almirall, S.A Recent Developments
Table 214. Aclaris Therapeutics Company Information
Table 215. Aclaris Therapeutics Description and Major Businesses
Table 216. Aclaris Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 217. Aclaris Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 218. Aclaris Therapeutics Recent Developments
Table 219. Taro Pharmaceutical Industries Company Information
Table 220. Taro Pharmaceutical Industries Description and Major Businesses
Table 221. Taro Pharmaceutical Industries Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 222. Taro Pharmaceutical Industries Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 223. Taro Pharmaceutical Industries Recent Developments
Table 224. Teligent Pharma Company Information
Table 225. Teligent Pharma Description and Major Businesses
Table 226. Teligent Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 227. Teligent Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 228. Teligent Pharma Recent Developments
Table 229. Perrigo Pharma Company Information
Table 230. Perrigo Pharma Description and Major Businesses
Table 231. Perrigo Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 232. Perrigo Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 233. Perrigo Pharma Recent Developments
Table 234. SigmaAldrich Company Information
Table 235. SigmaAldrich Description and Major Businesses
Table 236. SigmaAldrich Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 237. SigmaAldrich Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
Table 238. SigmaAldrich Recent Developments
Table 239. Key Raw Materials Lists
Table 240. Raw Materials Key Suppliers Lists
Table 241. Semi-solid Dosage Distributors List
Table 242. Semi-solid Dosage Customers List
Table 243. Semi-solid Dosage Market Trends
Table 244. Semi-solid Dosage Market Drivers
Table 245. Semi-solid Dosage Market Challenges
Table 246. Semi-solid Dosage Market Restraints
Table 247. Research Programs/Design for This Report
Table 248. Key Data Information from Secondary Sources
Table 249. Key Data Information from Primary Sources
List of Figures
Figure 1. Semi-solid Dosage Product Picture
Figure 2. Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Semi-solid Dosage Market Share by Type in 2023 & 2030
Figure 4. Ointment Product Picture
Figure 5. Paste Product Picture
Figure 6. Plaster Product Picture
Figure 7. Gel Product Picture
Figure 8. Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Semi-solid Dosage Market Share by Application in 2023 & 2030
Figure 10. Skin
Figure 11. Nasal Cavity
Figure 12. Vaginal Cavity
Figure 13. Rectal Cavity
Figure 14. Others
Figure 15. Semi-solid Dosage Report Years Considered
Figure 16. Global Semi-solid Dosage Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Semi-solid Dosage Revenue 2019-2030 (US$ Million)
Figure 18. Global Semi-solid Dosage Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Semi-solid Dosage Revenue Market Share by Region (2019-2030)
Figure 20. Global Semi-solid Dosage Sales 2019-2030 ((K Units)
Figure 21. Global Semi-solid Dosage Sales Market Share by Region (2019-2030)
Figure 22. US & Canada Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 23. US & Canada Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 25. Europe Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 27. China Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Asia (excluding China) Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 29. Asia (excluding China) Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Semi-solid Dosage Sales YoY (2019-2030) & (K Units)
Figure 31. Middle East, Africa and Latin America Semi-solid Dosage Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The Semi-solid Dosage Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 33. The Top 5 and 10 Largest Manufacturers of Semi-solid Dosage in the World: Market Share by Semi-solid Dosage Revenue in 2023
Figure 34. Global Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 36. Global Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 37. Global Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 38. Global Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 40. US & Canada Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 42. US & Canada Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Semi-solid Dosage Revenue Share by Country (2019-2030)
Figure 44. US & Canada Semi-solid Dosage Sales Share by Country (2019-2030)
Figure 45. U.S. Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 48. Europe Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 49. Europe Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 50. Europe Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 51. Europe Semi-solid Dosage Revenue Share by Country (2019-2030)
Figure 52. Europe Semi-solid Dosage Sales Share by Country (2019-2030)
Figure 53. Germany Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 54. France Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 58. China Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 59. China Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 60. China Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 61. China Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 62. Asia Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 63. Asia Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 64. Asia Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 65. Asia Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 66. Asia Semi-solid Dosage Revenue Share by Region (2019-2030)
Figure 67. Asia Semi-solid Dosage Sales Share by Region (2019-2030)
Figure 68. Japan Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 72. India Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Semi-solid Dosage Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Semi-solid Dosage Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Semi-solid Dosage Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Semi-solid Dosage Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Semi-solid Dosage Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America Semi-solid Dosage Sales Share by Country (2019-2030)
Figure 79. Brazil Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 82. Israel Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries Semi-solid Dosage Revenue (2019-2030) & (US$ Million)
Figure 84. Semi-solid Dosage Value Chain
Figure 85. Semi-solid Dosage Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232